The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER Database
Abstract
BACKGROUND: Current demographic, prognostic, and outcomes data on the diagnosis and treatment of chondrosarcoma have been based on case series reported by individual treatment centers. The SEER (Surveillance, Epidemiology and End Results) database is a validated national epidemiological surveillance system and cancer registry that has been used extensively to evaluate treatment outcomes in cases of malignancy. The purpose of the present study was to use this database to identify demographic and prognostic characteristics of chondrosarcoma and to describe the natural history following the treatment of this rare disease in the United States over the last thirty years. METHODS: Two thousand eight hundred and ninety patients with chondrosarcoma were identified in the SEER database, and information regarding the demographic and clinical characteristics of the patients, the histological features and grade of the tumors, the location and size of the tumors, the surgical stage at the time of diagnosis, the use of surgery and radiation treatment, and survival were extracted. RESULTS: Comparison of the overall and disease-specific survival rates revealed that patients who survived for ten years were more likely to die of events that were unrelated to chondrosarcoma. The disease-specific survival rate leveled off at ten years of follow-up. Univariate analysis revealed that female sex, a low histological grade, and local surgical stage were associated with a significant disease-specific survival benefit. An age of fifty years or less and an appendicular location of the tumor were associated with a significant overall survival benefit. On multivariate analysis, only grade and stage had significant association with disease-specific survival. On the basis of a comparison of survival rates according to the decade of diagnosis, it appears that there has been no significant improvement in survival over the last thirty years. CONCLUSIONS: Only grade and stage are independent prognostic factors for survival in cases of chondrosarcoma. Current treatment algorithms have not improved the survival rates of patients with chondrosarcoma over the past thirty years. Routine patient surveillance following treatment should be extended to ten years of follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
Hayat, M. J., Howlader, N., Reichman, M. E., & Edwards, B. K. (2007) · The Oncologist · doi:10.1634/theoncologist.12-1-20 · Cited by 1,096
The surveillance, epidemiology, and end results program: a national resource.
Hankey, B. F., Ries, L. A. G., & Edwards, B. K. (1999) · PubMed · Cited by 594
Osteosarcoma, Chondrosarcoma, and Ewing's Sarcoma: National Cancer Data Base Report
Damron, T. A., Ward, W. G., & Stewart, A. (2007) · Clinical Orthopaedics & Related Research · doi:10.1097/blo.0b013e318059b8c9 · Cited by 530
Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program
Gloeckler Ries, L. A., Reichman, M. E., Lewis, D. R., Hankey, B. F., & Edwards, B. K. (2003) · The Oncologist · doi:10.1634/theoncologist.8-6-541 · Cited by 487
Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli.
Gitelis, S., Bertoni, F., Picci, P., & Campanacci, M. (1981) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198163080-00006 · Cited by 222
Nattinger, A. B., McAuliffe, T. L., & Schapira, M. M. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00099-1 · Cited by 212
Analysing and interpreting competing risk data
Pintilie, M. (2007) · Statistics in Medicine · doi:10.1002/sim.2655 · Cited by 186
Reliability of Histopathologic and Radiologic Grading of Cartilaginous Neoplasms in Long Bones
the Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) Study Group (2007) · The Journal of Bone & Joint Surgery · doi:10.2106/jbjs.f.01530 · Cited by 164
Wingo, P. A., Jamison, P. M., Hiatt, R. A., Weir, H. K., Gargiullo, P. M., Hutton, M., Lee, N. C., & Hall, H. I. (2003) · Cancer Causes & Control · doi:10.1023/a:1023002322935 · Cited by 159
Cited by
HER-2 Immunohistochemical Expression in Bone Sarcomas: A New Hope for Osteosarcoma Patients
Khalifa, S. E., & Fathy, Y. (2018) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2018.318 · Cited by 20
Lyskjær, I., Davies, C., Strobl, A., Hindley, J., James, S., Lalam, R. K., Cross, W., Hide, G., Rankin, K. S., Jeys, L., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13102 · Cited by 16
Metadata
- Authors
- Giuffrida, A. Y., Burgueno, J. E., Koniaris, L. G., Gutierrez, J. C., Duncan, R., & Scully, S. P.
- Venue
- The Journal of Bone and Joint Surgery-American Volume
- Published
- 2009-05
- Volume
- 91
- Issue
- 5
- Pages
- 1063-1072
- ISSN
- 0021-9355 (ISSN-L)
- OpenAlex
- W2098245740
- Cited by
- 386
- References
- 15
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER Database. https://app.cochat.ai/papers/10.2106/jbjs.h.00416
- The paper
- Giuffrida, A. Y., Burgueno, J. E., Koniaris, L. G., Gutierrez, J. C., Duncan, R., & Scully, S. P. (2009). Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER Database. The Journal of Bone and Joint Surgery-American Volume. https://doi.org/10.2106/jbjs.h.00416
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.